trial
→
ReceivesAction
→
completed
|
0.70
|
|
trial
→
ReceivesAction
→
registered
|
0.70
|
|
trial
→
ReceivesAction
→
conducted
|
0.69
|
|
trial
→
ReceivesAction
→
conducted in accordance
|
0.68
|
|
trial
→
ReceivesAction
→
conducted in the united states
|
0.66
|
|
trial
→
ReceivesAction
→
concluded
|
0.66
|
|
trial
→
ReceivesAction
→
randomized
|
0.65
|
|
trial
→
ReceivesAction
→
excluded
|
0.65
|
|
trial
→
ReceivesAction
→
designed
|
0.65
|
|
trial
→
ReceivesAction
→
included in the analysis
|
0.64
|
|
trial
→
ReceivesAction
→
included in the meta-analysis
|
0.64
|
|
trial
→
ReceivesAction
→
held in the state
|
0.64
|
|
trial
→
ReceivesAction
→
run
|
0.63
|
|
trial
→
ReceivesAction
→
registered at clinicaltrials.gov
|
0.63
|
|
trial
→
ReceivesAction
→
designed to assess tolerability
|
0.61
|
|
trial
→
ReceivesAction
→
conducted in australia
|
0.61
|
|
trial
→
ReceivesAction
→
repeated
|
0.61
|
|
trial
→
ReceivesAction
→
recorded
|
0.61
|
|
trial
→
ReceivesAction
→
presented in random order
|
0.61
|
|
trial
→
ReceivesAction
→
analyzed
|
0.60
|
|
trial
→
ReceivesAction
→
conducted in compliance
|
0.60
|
|
trial
→
ReceivesAction
→
selected
|
0.59
|
|
trial
→
ReceivesAction
→
stopped
|
0.59
|
|
trial
→
ReceivesAction
→
initiated
|
0.59
|
|
trial
→
ReceivesAction
→
heard by judge
|
0.58
|
|
trial
→
ReceivesAction
→
conducted in europe
|
0.58
|
|
trial
→
ReceivesAction
→
combined
|
0.57
|
|
trial
→
ReceivesAction
→
concerned
|
0.57
|
|
trial
→
ReceivesAction
→
funded by grant
|
0.57
|
|
trial
→
ReceivesAction
→
carried out in accordance
|
0.57
|
|
trial
→
ReceivesAction
→
conducted in the uk
|
0.57
|
|
trial
→
ReceivesAction
→
conducted in china
|
0.56
|
|
trial
→
ReceivesAction
→
approved by institutional revie…
|
0.56
|
|
trial
→
ReceivesAction
→
shown
|
0.56
|
|
trial
→
ReceivesAction
→
conducted in india
|
0.56
|
|
trial
→
ReceivesAction
→
conducted in italy
|
0.56
|
|
trial
→
ReceivesAction
→
listed in table
|
0.56
|
|
trial
→
ReceivesAction
→
assessed for quality
|
0.56
|
|
trial
→
ReceivesAction
→
published in english
|
0.55
|
|
trial
→
ReceivesAction
→
scheduled for november
|
0.55
|
|
trial
→
ReceivesAction
→
approved by the ethics committee
|
0.55
|
|
trial
→
ReceivesAction
→
pooled
|
0.55
|
|
trial
→
ReceivesAction
→
implemented
|
0.55
|
|
trial
→
ReceivesAction
→
funded by industry
|
0.55
|
|
trial
→
ReceivesAction
→
conducted in asia
|
0.55
|
|
trial
→
ReceivesAction
→
held without jury
|
0.55
|
|
trial
→
ReceivesAction
→
of high quality
|
0.55
|
|
trial
→
ReceivesAction
→
conducted in 2013
|
0.55
|
|
trial
→
ReceivesAction
→
funded by pfizer
|
0.54
|
|
trial
→
ReceivesAction
→
suspended
|
0.54
|
|
trial
→
ReceivesAction
→
conducted in germany
|
0.54
|
|
trial
→
ReceivesAction
→
eligible for inclusion
|
0.54
|
|
trial
→
ReceivesAction
→
postponed
|
0.54
|
|
trial
→
ReceivesAction
→
sponsored by pharmaceutical com…
|
0.53
|
|
trial
→
ReceivesAction
→
funded by pharmaceutical compan…
|
0.53
|
|
trial
→
ReceivesAction
→
adjourned
|
0.53
|
|
trial
→
ReceivesAction
→
conducted in canada
|
0.53
|
|
trial
→
ReceivesAction
→
cancelled
|
0.52
|
|
trial
→
ReceivesAction
→
removed
|
0.52
|
|
trial
→
ReceivesAction
→
due to start
|
0.52
|
|
trial
→
ReceivesAction
→
ordered
|
0.52
|
|
trial
→
ReceivesAction
→
delayed
|
0.52
|
|
trial
→
ReceivesAction
→
held behind closed doors
|
0.52
|
|
trial
→
ReceivesAction
→
held in public
|
0.52
|
|
trial
→
ReceivesAction
→
presented in randomized order
|
0.52
|
|
trial
→
ReceivesAction
→
resolved
|
0.52
|
|
trial
→
ReceivesAction
→
conducted in patient
|
0.52
|
|
trial
→
ReceivesAction
→
reported
|
0.51
|
|
trial
→
ReceivesAction
→
replicated
|
0.51
|
|
trial
→
ReceivesAction
→
heard
|
0.51
|
|
trial
→
ReceivesAction
→
conducted in north america
|
0.51
|
|
trial
→
ReceivesAction
→
heard by jury
|
0.51
|
|
trial
→
ReceivesAction
→
put on hold
|
0.51
|
|
trial
→
ReceivesAction
→
completed in december
|
0.51
|
|
trial
→
ReceivesAction
→
held in open court
|
0.51
|
|
trial
→
ReceivesAction
→
regarded
|
0.51
|
|
trial
→
ReceivesAction
→
carried out in the usa
|
0.51
|
|
trial
→
ReceivesAction
→
continued
|
0.50
|
|
trial
→
ReceivesAction
→
discarded
|
0.50
|
|
trial
→
ReceivesAction
→
extended
|
0.50
|
|
trial
→
ReceivesAction
→
accepted
|
0.50
|
|
trial
→
ReceivesAction
→
arranged
|
0.50
|
|
trial
→
ReceivesAction
→
included in the cochrane review
|
0.50
|
|
trial
→
ReceivesAction
→
laid out in randomized complete…
|
0.50
|
|
trial
→
ReceivesAction
→
timed
|
0.50
|
|
trial
→
ReceivesAction
→
published in 2015
|
0.50
|
|
trial
→
ReceivesAction
→
sponsored by company
|
0.50
|
|
trial
→
ReceivesAction
→
limited
|
0.50
|
|
trial
→
ReceivesAction
→
biased
|
0.49
|
|
trial
→
ReceivesAction
→
inspected
|
0.49
|
|
trial
→
ReceivesAction
→
judged to be at low risk of bias
|
0.49
|
|
trial
→
ReceivesAction
→
reported in accordance
|
0.49
|
|
trial
→
ReceivesAction
→
carried out in europe
|
0.49
|
|
trial
→
ReceivesAction
→
rescheduled
|
0.49
|
|
trial
→
ReceivesAction
→
planned
|
0.49
|
|
trial
→
ReceivesAction
→
held
|
0.49
|
|
trial
→
ReceivesAction
→
conducted in japan
|
0.49
|
|
trial
→
ReceivesAction
→
set
|
0.49
|
|
trial
→
ReceivesAction
→
published in jama
|
0.49
|
|
trial
→
ReceivesAction
→
conducted in adult
|
0.49
|
|
trial
→
ReceivesAction
→
presented in pseudorandom order
|
0.49
|
|
trial
→
ReceivesAction
→
regulated
|
0.49
|
|
trial
→
ReceivesAction
→
sown
|
0.49
|
|
trial
→
ReceivesAction
→
published in journal
|
0.49
|
|
trial
→
ReceivesAction
→
conducted in child
|
0.48
|
|
trial
→
ReceivesAction
→
held in miami
|
0.48
|
|
trial
→
ReceivesAction
→
televised
|
0.48
|
|
trial
→
ReceivesAction
→
published in 2004
|
0.47
|
|
trial
→
ReceivesAction
→
closed
|
0.47
|
|
trial
→
ReceivesAction
→
designed to evaluate safety
|
0.47
|
|
trial
→
ReceivesAction
→
terminated
|
0.47
|
|
trial
→
ReceivesAction
→
filmed
|
0.47
|
|
trial
→
ReceivesAction
→
flawed
|
0.47
|
|
trial
→
ReceivesAction
→
held in the united states
|
0.47
|
|
trial
→
ReceivesAction
→
included in systematic review
|
0.47
|
|
trial
→
ReceivesAction
→
conducted in partnership
|
0.47
|
|
trial
→
ReceivesAction
→
abandoned
|
0.46
|
|
trial
→
ReceivesAction
→
completed in march
|
0.46
|
|
trial
→
ReceivesAction
→
conducted in country
|
0.46
|
|
trial
→
ReceivesAction
→
identified
|
0.46
|
|
trial
→
ReceivesAction
→
conducted in collaboration
|
0.46
|
|
trial
→
ReceivesAction
→
tried
|
0.46
|
|
trial
→
ReceivesAction
→
collected
|
0.46
|
|
trial
→
ReceivesAction
→
conducted in hospital
|
0.46
|
|
trial
→
ReceivesAction
→
conducted in high-income countr…
|
0.46
|
|
trial
→
ReceivesAction
→
rejected
|
0.46
|
|
trial
→
ReceivesAction
→
conducted in argentina
|
0.45
|
|
trial
→
ReceivesAction
→
published in the bmj
|
0.45
|
|
trial
→
ReceivesAction
→
closed to the public
|
0.45
|
|
trial
→
ReceivesAction
→
designed to assess efficacy
|
0.45
|
|
trial
→
ReceivesAction
→
set for june
|
0.45
|
|
trial
→
ReceivesAction
→
of low quality
|
0.45
|
|
trial
→
ReceivesAction
→
conducted on treatment
|
0.45
|
|
trial
→
ReceivesAction
→
conducted on human
|
0.45
|
|
trial
→
ReceivesAction
→
sponsored by the national cance…
|
0.45
|
|
trial
→
ReceivesAction
→
related
|
0.45
|
|
trial
→
ReceivesAction
→
sponsored by nih
|
0.45
|
|
trial
→
ReceivesAction
→
targeted
|
0.45
|
|
trial
→
ReceivesAction
→
conducted on people
|
0.45
|
|
trial
→
ReceivesAction
→
averaged
|
0.45
|
|
trial
→
ReceivesAction
→
offered by the business
|
0.44
|
|
trial
→
ReceivesAction
→
scheduled for september
|
0.44
|
|
trial
→
ReceivesAction
→
held in april
|
0.44
|
|
trial
→
ReceivesAction
→
designed to evaluate pharmacoki…
|
0.44
|
|
trial
→
ReceivesAction
→
scheduled
|
0.44
|
|
trial
→
ReceivesAction
→
funded by the national institut…
|
0.44
|
|
trial
→
ReceivesAction
→
held in march
|
0.44
|
|
trial
→
ReceivesAction
→
monitored
|
0.44
|
|
trial
→
ReceivesAction
→
funded by the national institute
|
0.43
|
|
trial
→
ReceivesAction
→
set for february
|
0.43
|
|
trial
→
ReceivesAction
→
established
|
0.43
|
|
trial
→
ReceivesAction
→
had
|
0.43
|
|
trial
→
ReceivesAction
→
organized
|
0.43
|
|
trial
→
ReceivesAction
→
rigged
|
0.43
|
|
trial
→
ReceivesAction
→
won
|
0.42
|
|
trial
→
ReceivesAction
→
conducted in france
|
0.42
|
|
trial
→
ReceivesAction
→
conducted at two prestigious ca…
|
0.42
|
|
trial
→
ReceivesAction
→
completed by particular tribunal
|
0.42
|
|
trial
→
ReceivesAction
→
registered with the chinese cli…
|
0.42
|
|
trial
→
ReceivesAction
→
scheduled for january
|
0.42
|
|
trial
→
ReceivesAction
→
allowed
|
0.42
|
|
trial
→
ReceivesAction
→
conducted in addition
|
0.42
|
|
trial
→
ReceivesAction
→
scheduled for may
|
0.42
|
|
trial
→
ReceivesAction
→
expected
|
0.42
|
|
trial
→
ReceivesAction
→
likely to published
|
0.42
|
|
trial
→
ReceivesAction
→
resumed
|
0.42
|
|
trial
→
ReceivesAction
→
scheduled for october
|
0.42
|
|
trial
→
ReceivesAction
→
about to begin
|
0.41
|
|
trial
→
ReceivesAction
→
overcome
|
0.41
|
|
trial
→
ReceivesAction
→
funded by the medical research …
|
0.41
|
|
trial
→
ReceivesAction
→
held in nuremberg
|
0.41
|
|
trial
→
ReceivesAction
→
held in secret
|
0.41
|
|
trial
→
ReceivesAction
→
launched
|
0.41
|
|
trial
→
ReceivesAction
→
recommended
|
0.41
|
|
trial
→
ReceivesAction
→
conducted in south africa
|
0.41
|
|
trial
→
ReceivesAction
→
followed
|
0.41
|
|
trial
→
ReceivesAction
→
understood
|
0.41
|
|
trial
→
ReceivesAction
→
warranted
|
0.41
|
|
trial
→
ReceivesAction
→
carried out in germany
|
0.41
|
|
trial
→
ReceivesAction
→
scheduled for july
|
0.41
|
|
trial
→
ReceivesAction
→
separated
|
0.41
|
|
trial
→
ReceivesAction
→
reported as abstract
|
0.40
|
|
trial
→
ReceivesAction
→
broadcast
|
0.40
|
|
trial
→
ReceivesAction
→
submitted to the fda
|
0.40
|
|
trial
→
ReceivesAction
→
expanded
|
0.40
|
|
trial
→
ReceivesAction
→
created
|
0.39
|
|
trial
→
ReceivesAction
→
judged to be at high risk of bi…
|
0.39
|
|
trial
→
ReceivesAction
→
examined
|
0.39
|
|
trial
→
ReceivesAction
→
held in january
|
0.39
|
|
trial
→
ReceivesAction
→
scheduled to begin in march
|
0.39
|
|
trial
→
ReceivesAction
→
developed
|
0.39
|
|
trial
→
ReceivesAction
→
funded by cancer research uk
|
0.39
|
|
trial
→
ReceivesAction
→
funded by merck
|
0.39
|
|
trial
→
ReceivesAction
→
due to finish
|
0.38
|
|
trial
→
ReceivesAction
→
scheduled for december
|
0.38
|
|
trial
→
ReceivesAction
→
changed
|
0.38
|
|
trial
→
ReceivesAction
→
conducted outside the u.s.
|
0.38
|
|
trial
→
ReceivesAction
→
held in court
|
0.38
|
|
trial
→
ReceivesAction
→
adjourned until may
|
0.38
|
|
trial
→
ReceivesAction
→
announced
|
0.38
|
|
trial
→
ReceivesAction
→
led by researcher
|
0.38
|
|
trial
→
ReceivesAction
→
likely to be valid
|
0.38
|
|
trial
→
ReceivesAction
→
published in the lancet
|
0.38
|
|
trial
→
ReceivesAction
→
pushed
|
0.38
|
|
trial
→
ReceivesAction
→
scheduled to begin on april
|
0.38
|
|
trial
→
ReceivesAction
→
scheduled to start in february
|
0.38
|
|
trial
→
ReceivesAction
→
adjourned until november
|
0.38
|
|
trial
→
ReceivesAction
→
conducted in 2014
|
0.38
|
|
trial
→
ReceivesAction
→
due to end
|
0.38
|
|
trial
→
ReceivesAction
→
held in february
|
0.38
|
|
trial
→
ReceivesAction
→
held in july
|
0.38
|
|
trial
→
ReceivesAction
→
re
|
0.38
|
|
trial
→
ReceivesAction
→
carried out in canada
|
0.37
|
|
trial
→
ReceivesAction
→
conducted in the netherlands
|
0.37
|
|
trial
→
ReceivesAction
→
funded by blood institute
|
0.37
|
|
trial
→
ReceivesAction
→
held in august
|
0.37
|
|
trial
→
ReceivesAction
→
postponed to march
|
0.37
|
|
trial
→
ReceivesAction
→
published in 2016
|
0.37
|
|
trial
→
ReceivesAction
→
aborted
|
0.37
|
|
trial
→
ReceivesAction
→
conducted in 2017
|
0.37
|
|
trial
→
ReceivesAction
→
funded by astrazeneca
|
0.37
|
|
trial
→
ReceivesAction
→
funded by the national heart
|
0.37
|
|
trial
→
ReceivesAction
→
held before the international m…
|
0.37
|
|
trial
→
ReceivesAction
→
convicted
|
0.37
|
|
trial
→
ReceivesAction
→
listed on clinicaltrials.gov
|
0.36
|
|
trial
→
ReceivesAction
→
approved by the fda
|
0.36
|
|
trial
→
ReceivesAction
→
held before u.s. military courts
|
0.36
|
|
trial
→
ReceivesAction
→
held in october
|
0.36
|
|
trial
→
ReceivesAction
→
published in 2012
|
0.36
|
|
trial
→
ReceivesAction
→
set for august
|
0.36
|
|
trial
→
ReceivesAction
→
added
|
0.36
|
|
trial
→
ReceivesAction
→
conducted in new zealand
|
0.36
|
|
trial
→
ReceivesAction
→
conducted in south korea
|
0.36
|
|
trial
→
ReceivesAction
→
conducted in spain
|
0.36
|
|
trial
→
ReceivesAction
→
divided into three phases
|
0.36
|
|
trial
→
ReceivesAction
→
funded by the nih
|
0.36
|
|
trial
→
ReceivesAction
→
held in federal court
|
0.36
|
|
trial
→
ReceivesAction
→
held on saturday
|
0.36
|
|
trial
→
ReceivesAction
→
set for monday
|
0.36
|
|
trial
→
ReceivesAction
→
allowed in said court
|
0.36
|
|
trial
→
ReceivesAction
→
conducted in belgium
|
0.36
|
|
trial
→
ReceivesAction
→
conducted in uganda
|
0.36
|
|
trial
→
ReceivesAction
→
held in camera
|
0.36
|
|
trial
→
ReceivesAction
→
prepared
|
0.36
|
|
trial
→
ReceivesAction
→
proposed
|
0.36
|
|
trial
→
ReceivesAction
→
registered with isrctn
|
0.36
|
|
trial
→
ReceivesAction
→
restricted to patient
|
0.36
|
|
trial
→
ReceivesAction
→
sponsored by the university of …
|
0.36
|
|
trial
→
ReceivesAction
→
waived
|
0.36
|
|
trial
→
ReceivesAction
→
watched
|
0.36
|
|
trial
→
ReceivesAction
→
written by franz kafka
|
0.36
|
|
trial
→
ReceivesAction
→
conducted in finland
|
0.35
|
|
trial
→
ReceivesAction
→
conducted in mexico
|
0.35
|
|
trial
→
ReceivesAction
→
expedited
|
0.35
|
|
trial
→
ReceivesAction
→
funded by the wellcome trust
|
0.35
|
|
trial
→
ReceivesAction
→
held in new york city
|
0.35
|
|
trial
→
ReceivesAction
→
passed
|
0.35
|
|
trial
→
ReceivesAction
→
protected
|
0.35
|
|
trial
→
ReceivesAction
→
published in 2005
|
0.35
|
|
trial
→
ReceivesAction
→
published in 2010
|
0.35
|
|
trial
→
ReceivesAction
→
published to date
|
0.35
|
|
trial
→
ReceivesAction
→
sponsored by novartis
|
0.35
|
|
trial
→
ReceivesAction
→
sponsored by the national heart
|
0.35
|
|
trial
→
ReceivesAction
→
found unto glory
|
0.35
|
|
trial
→
ReceivesAction
→
based on evidence
|
0.34
|
|
trial
→
ReceivesAction
→
based on fact
|
0.34
|
|
trial
→
ReceivesAction
→
conducted in kenya
|
0.34
|
|
trial
→
ReceivesAction
→
conducted in melbourne
|
0.34
|
|
trial
→
ReceivesAction
→
conducted in parallel
|
0.34
|
|
trial
→
ReceivesAction
→
designed to assess effectiveness
|
0.34
|
|
trial
→
ReceivesAction
→
eliminated
|
0.34
|
|
trial
→
ReceivesAction
→
handled
|
0.34
|
|
trial
→
ReceivesAction
→
held at the old bailey
|
0.34
|
|
trial
→
ReceivesAction
→
published in 2011
|
0.34
|
|
trial
→
ReceivesAction
→
restarted
|
0.34
|
|
trial
→
ReceivesAction
→
scored
|
0.34
|
|
trial
→
ReceivesAction
→
sponsored by blood
|
0.34
|
|
trial
→
ReceivesAction
→
stopped for efficacy
|
0.34
|
|
trial
→
ReceivesAction
→
omitted
|
0.34
|
|
trial
→
ReceivesAction
→
used by god
|
0.34
|
|
trial
→
ReceivesAction
→
bifurcated
|
0.34
|
|
trial
→
ReceivesAction
→
broadcast on television
|
0.34
|
|
trial
→
ReceivesAction
→
conducted in africa
|
0.34
|
|
trial
→
ReceivesAction
→
conducted in brazil
|
0.34
|
|
trial
→
ReceivesAction
→
conducted in sydney
|
0.34
|
|
trial
→
ReceivesAction
→
funded by the charity
|
0.34
|
|
trial
→
ReceivesAction
→
held at the start of the year
|
0.34
|
|
trial
→
ReceivesAction
→
likely to result
|
0.34
|
|
trial
→
ReceivesAction
→
performed on larger groups
|
0.34
|
|
trial
→
ReceivesAction
→
presided by judge
|
0.34
|
|
trial
→
ReceivesAction
→
set for next month
|
0.34
|
|
trial
→
ReceivesAction
→
sponsored by eli lilly
|
0.34
|
|
trial
→
ReceivesAction
→
stayed
|
0.34
|
|
trial
→
ReceivesAction
→
structured
|
0.34
|
|
trial
→
ReceivesAction
→
never published
|
0.33
|
|
trial
→
ReceivesAction
→
adapted
|
0.33
|
|
trial
→
ReceivesAction
→
adjourned to another date
|
0.33
|
|
trial
→
ReceivesAction
→
completed in january
|
0.33
|
|
trial
→
ReceivesAction
→
completed in june
|
0.33
|
|
trial
→
ReceivesAction
→
conducted by a team of individu…
|
0.33
|
|
trial
→
ReceivesAction
→
conducted in english
|
0.33
|
|
trial
→
ReceivesAction
→
conducted in south america
|
0.33
|
|
trial
→
ReceivesAction
→
conducted in sweden
|
0.33
|
|
trial
→
ReceivesAction
→
conducted in thailand
|
0.33
|
|
trial
→
ReceivesAction
→
funded by the department
|
0.33
|
|
trial
→
ReceivesAction
→
given with paclitaxel
|
0.33
|
|
trial
→
ReceivesAction
→
likely to begin
|
0.33
|
|
trial
→
ReceivesAction
→
published in march
|
0.33
|
|
trial
→
ReceivesAction
→
sponsored by the national center
|
0.33
|
|
trial
→
ReceivesAction
→
sponsored by the nci
|
0.33
|
|
trial
→
ReceivesAction
→
avoided
|
0.33
|
|
trial
→
ReceivesAction
→
criticized
|
0.33
|
|
trial
→
ReceivesAction
→
adjourned for week
|
0.32
|
|
trial
→
ReceivesAction
→
adjourned until february
|
0.32
|
|
trial
→
ReceivesAction
→
administered
|
0.32
|
|
trial
→
ReceivesAction
→
approved by health canada
|
0.32
|
|
trial
→
ReceivesAction
→
completed in february
|
0.32
|
|
trial
→
ReceivesAction
→
completed under nct02722408
|
0.32
|
|
trial
→
ReceivesAction
→
conducted at site
|
0.32
|
|
trial
→
ReceivesAction
→
conducted by a research team
|
0.32
|
|
trial
→
ReceivesAction
→
conducted in absentia
|
0.32
|
|
trial
→
ReceivesAction
→
conducted in costa rica
|
0.32
|
|
trial
→
ReceivesAction
→
conducted in switzerland
|
0.32
|
|
trial
→
ReceivesAction
→
demanded
|
0.32
|
|
trial
→
ReceivesAction
→
designed to evaluate following …
|
0.32
|
|
trial
→
ReceivesAction
→
designed to evaluate immunogeni…
|
0.32
|
|
trial
→
ReceivesAction
→
dismissed
|
0.32
|
|
trial
→
ReceivesAction
→
divided into two groups
|
0.32
|
|
trial
→
ReceivesAction
→
explored
|
0.32
|
|
trial
→
ReceivesAction
→
funded by nonprofit or nonfeder…
|
0.32
|
|
trial
→
ReceivesAction
→
funded by the national institut…
|
0.32
|
|
trial
→
ReceivesAction
→
held in september
|
0.32
|
|
trial
→
ReceivesAction
→
known in each state
|
0.32
|
|
trial
→
ReceivesAction
→
led by the world health organiz…
|
0.32
|
|
trial
→
ReceivesAction
→
overseen by a steering committee
|
0.32
|
|
trial
→
ReceivesAction
→
published in 2008
|
0.32
|
|
trial
→
ReceivesAction
→
run with school
|
0.32
|
|
trial
→
ReceivesAction
→
scheduled for next year
|
0.32
|
|
trial
→
ReceivesAction
→
discontinued
|
0.32
|
|
trial
→
ReceivesAction
→
appointed to be had before the …
|
0.32
|
|
trial
→
ReceivesAction
→
approved by local ethics commit…
|
0.32
|
|
trial
→
ReceivesAction
→
completed on time
|
0.32
|
|
trial
→
ReceivesAction
→
conducted at 5 locations
|
0.32
|
|
trial
→
ReceivesAction
→
conducted at the university of …
|
0.32
|
|
trial
→
ReceivesAction
→
conducted at the university of …
|
0.32
|
|
trial
→
ReceivesAction
→
conducted in 1970
|
0.32
|
|
trial
→
ReceivesAction
→
conducted in peru
|
0.32
|
|
trial
→
ReceivesAction
→
confirmed
|
0.32
|
|
trial
→
ReceivesAction
→
constructed
|
0.32
|
|
trial
→
ReceivesAction
→
designed in consultation
|
0.32
|
|
trial
→
ReceivesAction
→
designed to answer the question
|
0.32
|
|
trial
→
ReceivesAction
→
due to last
|
0.32
|
|
trial
→
ReceivesAction
→
established in cooperation
|
0.32
|
|
trial
→
ReceivesAction
→
fought
|
0.32
|
|
trial
→
ReceivesAction
→
funded by melinda gates foundat…
|
0.32
|
|
trial
→
ReceivesAction
→
funded by niaid
|
0.32
|
|
trial
→
ReceivesAction
→
funded by two uk funding agenci…
|
0.32
|
|
trial
→
ReceivesAction
→
guaranteed
|
0.32
|
|
trial
→
ReceivesAction
→
had on complaint
|
0.32
|
|
trial
→
ReceivesAction
→
held at special court
|
0.32
|
|
trial
→
ReceivesAction
→
held in closed session
|
0.32
|
|
trial
→
ReceivesAction
→
held in scotland
|
0.32
|
|
trial
→
ReceivesAction
→
held in the netherlands
|
0.32
|
|
trial
→
ReceivesAction
→
joined with date
|
0.32
|
|
trial
→
ReceivesAction
→
postponed to september
|
0.32
|
|
trial
→
ReceivesAction
→
proceeded
|
0.32
|
|
trial
→
ReceivesAction
→
published in 1996
|
0.32
|
|
trial
→
ReceivesAction
→
published in 2007
|
0.32
|
|
trial
→
ReceivesAction
→
published in abstract form
|
0.32
|
|
trial
→
ReceivesAction
→
published in peer-reviewed jour…
|
0.32
|
|
trial
→
ReceivesAction
→
published since 2002
|
0.32
|
|
trial
→
ReceivesAction
→
registered in the dutch trial r…
|
0.32
|
|
trial
→
ReceivesAction
→
set within 6 judicial workingda…
|
0.32
|
|
trial
→
ReceivesAction
→
shown in figure
|
0.32
|
|
trial
→
ReceivesAction
→
split into two parts
|
0.32
|
|
trial
→
ReceivesAction
→
sponsored by other federal agen…
|
0.32
|
|
trial
→
ReceivesAction
→
staged
|
0.32
|
|
trial
→
ReceivesAction
→
lost
|
0.31
|
|
trial
→
ReceivesAction
→
announced in january
|
0.31
|
|
trial
→
ReceivesAction
→
completed in november
|
0.31
|
|
trial
→
ReceivesAction
→
concluded in two years
|
0.31
|
|
trial
→
ReceivesAction
→
conducted by the national cance…
|
0.31
|
|
trial
→
ReceivesAction
→
conducted in august
|
0.31
|
|
trial
→
ReceivesAction
→
conducted in israel
|
0.31
|
|
trial
→
ReceivesAction
→
conducted in london
|
0.31
|
|
trial
→
ReceivesAction
→
designed to evaluate the propor…
|
0.31
|
|
trial
→
ReceivesAction
→
funded by the bill
|
0.31
|
|
trial
→
ReceivesAction
→
held in a lucknow court
|
0.31
|
|
trial
→
ReceivesAction
→
held in courtroom
|
0.31
|
|
trial
→
ReceivesAction
→
intermixed
|
0.31
|
|
trial
→
ReceivesAction
→
judged on speed
|
0.31
|
|
trial
→
ReceivesAction
→
presented in total
|
0.31
|
|
trial
→
ReceivesAction
→
published in the nejm
|
0.31
|
|
trial
→
ReceivesAction
→
scheduled to begin may
|
0.31
|
|
trial
→
ReceivesAction
→
sponsored by academic instituti…
|
0.31
|
|
trial
→
ReceivesAction
→
sponsored by institute
|
0.31
|
|
trial
→
ReceivesAction
→
sponsored by roche
|
0.31
|
|
trial
→
ReceivesAction
→
ignored
|
0.31
|
|
trial
→
ReceivesAction
→
compared
|
0.30
|
|
trial
→
ReceivesAction
→
found unto honour
|
0.30
|
|
trial
→
ReceivesAction
→
conducted to date
|
0.29
|
|
trial
→
ReceivesAction
→
stopped for futility
|
0.29
|
|
trial
→
ReceivesAction
→
difficult to conduct
|
0.28
|
|
trial
→
ReceivesAction
→
delayed by procedural matters
|
0.27
|
|
trial
→
ReceivesAction
→
interrupted
|
0.26
|
|
trial
→
ReceivesAction
→
conducted in way
|
0.26
|
|
trial
→
ReceivesAction
→
published in chinese journals
|
0.26
|
|
trial
→
ReceivesAction
→
politicised
|
0.25
|
|
trial
→
ReceivesAction
→
demolished by investigator
|
0.24
|
|
trial
→
ReceivesAction
→
abolished
|
0.24
|
|
trial
→
ReceivesAction
→
charged with murder
|
0.24
|
|
trial
→
ReceivesAction
→
conducted in much informal fash…
|
0.24
|
|
trial
→
ReceivesAction
→
considered harmful
|
0.24
|
|
trial
→
ReceivesAction
→
likely to succeed
|
0.24
|
|
trial
→
ReceivesAction
→
prejudiced
|
0.24
|
|
trial
→
ReceivesAction
→
tainted
|
0.24
|
|
trial
→
ReceivesAction
→
condemned by international comm…
|
0.23
|
|
trial
→
ReceivesAction
→
marred by delay
|
0.23
|
|
trial
→
ReceivesAction
→
stalled
|
0.23
|
|
trial
→
ReceivesAction
→
accused of crime
|
0.22
|
|
trial
→
ReceivesAction
→
published in non-chinese journa…
|
0.22
|
|
trial
→
ReceivesAction
→
instituted
|
0.22
|
|
trial
→
ReceivesAction
→
published in the british medica…
|
0.21
|
|
trial
→
ReceivesAction
→
delayed for year
|
0.21
|
|
trial
→
ReceivesAction
→
fixed
|
0.18
|
|
trial
→
ReceivesAction
→
dropped
|
0.16
|
|
trial
→
ReceivesAction
→
requested
|
0.15
|
|
trial
→
ReceivesAction
→
authorised
|
0.15
|
|